COVID-19 Vaccinations
Vaccinations
A vaccine is designed to boost our natural immune response to an invading virus. The vaccination helps the body recognize antigens on pathogens outer surface. The body’s immune system responds to the presence of these antigens by producing special immune cells (white blood cells) that directly attack the pathogen, or by producing proteins called antibodies. The antibodies attach to an antigen creating a complex that sets off the bodies alarm system to attract immune cells that engulf and destroy the pathogen complex.
The vaccination is the strategic game plan that we have rehearsed during our pregame exercises, it’s going to give us humans a leg up during the main event, the illness. Think of a vaccine like a pregame exercise before the big championship battle of Human vs Pathogen.
COVID-19 Vaccine:
Helps protect you from getting COVID-19
Click on your State below for their COVID-19 Vaccination information website
Vaccines to protect against COVID-19 are now available in limited quantities in the United States and recommended for specific groups.
VaccineFinder will be updated once COVID-19 vaccination is widely available to the public to help direct people to find a vaccine provider near them.
Pharmacies nationwide participating in COVID-19 vaccination programs
Sign Up for COVID-19 Vaccine Information
Our pharmacies will be administering COVID-19 vaccines as soon as they are available, in accordance with CDC and state guidelines.
Stay informed about the no-cost COVID-19 vaccine.*
We are administering the COVID-19 vaccine in limited areas by appointment only.
Appointment-only clinics will be hosted for phases 1A and 1B in certain communities. An appointment must be booked. Walk-ins will not be accepted.
Hy-Vee Selected to Administer COVID-19 Vaccines
Our family of pharmacies has received a limited supply of the COVID-19 vaccine in select areas and our licensed health care professionals are partnering with federal and state agencies to administer the doses in accordance with each jurisdiction’s rollout plans.
At Publix, our goal is to provide you up-to-date information on how to get your vaccine at select Publix pharmacies if you are eligible, while supplies last.
Through our partnership with the CDC, all of Rite Aid locations are staged and ready to administer the vaccine as soon as available for pharmacy distribution.
We're following state-specific eligibility requirements for vaccinating priority populations.*
Winn-Dixie customers will be the first to know when the COVID-19 vaccine becomes available for us to administer.
Information about the current authorized vaccinations
Moderna’s vaccine against COVID-19
Requires two doses
Second dose must be administered 28 days after the first dose
94.1% overall efficacy in preventing symptomatic COVID-19 infection
86.4% efficacy in people 65 or older
Vaccination available for Adults 18 and older
Moderna is still testing the vaccine in children ages 12-17
Moderna is proud to be among the many groups working to respond to this continuing global health emergency.
Pfizer-BioNTech Co-Developed COVID-19 Vaccine
Requires two doses
Second dose must be administered 21 days after the first dose
95% overall efficacy in preventing symptomatic COVID-19 infection
Vaccination available for anyone 16 and older
Pfizer-BioNTech is still testing the vaccine in kids ages 12-15
Collaboration aims to accelerate global development of BNT162, mRNA-based influenza vaccine
Johnson & Johnson COVID-19 vaccination
Single dose
Vaccine is estimated to remain stable for two years at -25 to -15°C, and a maximum of three months of which can be at routine refrigeration at temperatures of 2°-8°C
72% overall efficacy
85% efficacy in preventing severe COVID-19 infection
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S.
Vaccinations currently still being investigated
GSK potential Adjuvant COVID-19 Vaccination
GSK is entering into the new collaborative research effort, the COVID-19 Therapeutics Accelerator.
AstraZeneca COVID-19 vaccination
AstraZeneca’s COVID-19 vaccine authorized for emergency supply outside of the U.S.
Sanofi Pasteur announces potential vaccine development
Sanofi Pasteur, the vaccines global business unit of Sanofi, is leveraging previous development work for a SARS vaccine as part of our goal to unlock a fast path forward for developing a COVID-19 vaccine.
Inovio potential COVID-19 Vaccination
U.S. Food and Drug Administration has accepted the company's New Drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent COVID-19 infection